Amgen Boosts FY23 Total Revenues Outlook From $26.2B-$27.3B To $26.6B-$27.4B, Consensus $26.56B
Portfolio Pulse from Benzinga Newsdesk
Amgen has raised its FY23 total revenues outlook from $26.2B-$27.3B to $26.6B-$27.4B, surpassing the consensus estimate of $26.56B.
August 04, 2023 | 2:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen has increased its FY23 total revenues outlook, which is now above the consensus estimate. This could potentially lead to a positive market reaction.
Amgen's upward revision of its FY23 total revenues outlook, which is now above the consensus estimate, is a positive signal to the market. This could lead to increased investor confidence in the company's performance and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100